You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Business & Finance
Abbott announces quarterly common dividend
22 September 2025 -

Global healthcare company Abbott (NYSE:ABT) announced on Friday a quarterly dividend of USD0.59 per share of common stock.

This amount is unchanged from the previous quarterly dividend.

It will be paid on 17 November 2025 to shareholders of record as of 15 October 2025.

Login
Username:

Password:


Related Headlines

Abbott announces quarterly common dividend

CVS Health declares unchanged quarterly dividend

ALK partners with GenSci to expand allergy immunotherapy market in China

Curatis secures Swiss distribution deal with Phoenix Labs

Innocan Pharma reports 'positive swing' in operating profitability for first half of 2025

Wolters Kluwer boosts medical research efficiency with Ovid AI summarisation

European Commission approves Gilead's twice-yearly HIV prevention injection Yeytuo

Essa Pharma clarifies Nasdaq due bill trading period for cash distribution

Advanz Pharma and Alvotech secure European approval for aflibercept biosimilar Mynzepli

Heron Therapeutics announces tax benefits preservation plan adoption

Essa Pharma sets ex-dividend date and due bill trading for USD80m capital return

BioDlink's bevacizumab injection secures Colombia and Pakistan marketing authorisation

GSK to receive USD370m and future royalties in CureVac/BioNTech settlement

Everest Medicines expands I-MAB investment

Perrigo Announces Quarterly Dividend

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2025